[go: up one dir, main page]

ES2075797B1 - DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE. - Google Patents

DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE.

Info

Publication number
ES2075797B1
ES2075797B1 ES9301818A ES9301818A ES2075797B1 ES 2075797 B1 ES2075797 B1 ES 2075797B1 ES 9301818 A ES9301818 A ES 9301818A ES 9301818 A ES9301818 A ES 9301818A ES 2075797 B1 ES2075797 B1 ES 2075797B1
Authority
ES
Spain
Prior art keywords
compounds
medicine
derivatives
contain
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9301818A
Other languages
Spanish (es)
Other versions
ES2075797A1 (en
Inventor
Jonathon Philip Dickens
Raymond John Crimmin
Raymond Paul Beckett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Bio Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Bio Technology Ltd filed Critical British Bio Technology Ltd
Priority to ES9301818A priority Critical patent/ES2075797B1/en
Publication of ES2075797A1 publication Critical patent/ES2075797A1/en
Application granted granted Critical
Publication of ES2075797B1 publication Critical patent/ES2075797B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DERIVADOS DE ACIDOS HIDROXAMICOS TERAPEUTICAMENTE ACTIVOS, PROCEDIMIENTOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y EL USO DE DICHOS COMPUESTOS EN MEDICINA. LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE ACIDO HIDROXAMICOS TERAPEUTICOS ACTIVOS, A PROCEDIMIENTOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y AL USO DE DICHOS COMPUESTOS EN MEDICINA, CONCRETAMENTE COMPUESTOS DE FORMULA (I): EN LA QUE - R2 ES UN GRUPO R6-A- DONDE A REPRESENTA UNA CADENA DIVALENTE HIDROCARBONADA, SATURADA O NO SATURADA, LINEAL O RAMIFICADA; - R3 ES UN GRUPO R7-(BN)-, EN DONDE N ES 0 O 1, B ES UNA CADENA DIVALENTE HIDROCARBONADA SATURADA O NO SATURADA, LINEAL O RAMIFICADA; - R4 ES HIDROGENO O METILO; - R5 ES HIDROGENO, O UN GRUPO ALQUILO O AMINO - O R3 Y R5, TOMADOS CONJUNTAMENTE, REPRESENTAN UNA CADENA DIVALENTE HIDROCARBONADA; ESTOS COMPUESTOS INHIBEN LA ACCION DE METALOPROTEINASAS Y SON UTILES PARA EL TRATAMIENTO O PROFILAXIS DE ESTADOS QUE OCASIONAN LA DESINTEGRACION DE TEJIDOS.DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE. THE PRESENT INVENTION REFERS TO DERIVATIVES OF ACTIVE THERAPEUTIC HYDROXAMIC ACIDS, TO PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND TO THE USE OF SUCH COMPOUNDS IN MEDICINE, WHICH IS A6 - I: R2: -A- WHERE A HYDROCARBON DIVALENT, SATURATED OR NOT SATURATED, LINEAR OR BRANCHED REPRESENTS; - R3 IS A GROUP R7- (BN) -, WHERE N IS 0 O 1, B IS A DIVALENT HYDROCARBON CHAIN SATURATED OR NOT SATURATED, LINEAR OR BRANCHED; - R4 IS HYDROGEN OR METHYL; - R5 IS HYDROGEN, OR AN ALKYL OR AMINO GROUP - OR R3 AND R5, TAKEN TOGETHER, REPRESENT A DIVALENT HYDROCARBON CHAIN; THESE COMPOUNDS INHIBIT THE ACTION OF METALOPROTEINASES AND ARE USEFUL FOR THE TREATMENT OR PROPHYLAXIS OF STATES THAT CAUSE THE DISINTEGRATION OF TISSUES.

ES9301818A 1993-08-18 1993-08-18 DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE. Expired - Fee Related ES2075797B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301818A ES2075797B1 (en) 1993-08-18 1993-08-18 DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301818A ES2075797B1 (en) 1993-08-18 1993-08-18 DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE.

Publications (2)

Publication Number Publication Date
ES2075797A1 ES2075797A1 (en) 1995-10-01
ES2075797B1 true ES2075797B1 (en) 1996-05-16

Family

ID=8282876

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301818A Expired - Fee Related ES2075797B1 (en) 1993-08-18 1993-08-18 DERIVATIVES OF THERAPEUTICALLY ACTIVE HYDROXAMIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH COMPOUNDS IN MEDICINE.

Country Status (1)

Country Link
ES (1) ES2075797B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds

Also Published As

Publication number Publication date
ES2075797A1 (en) 1995-10-01

Similar Documents

Publication Publication Date Title
ES2128791T3 (en) SPIROCETAL DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS THERAPEUTIC AGENTS.
ES2166823T3 (en) NEW PIRROLIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2084944T3 (en) THERAPEUTIC AMIDES.
AR012671A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PROPHYLAXIS OF THE CONSTIPATION, THE USES OF SUCH COMPOSITIONS AND THE PROCESSES TO PREPARE THEM
AR002718A1 (en) HYDROXAMIC ACIDS THAT CONTAIN LACTAMS AND PHARMACEUTICAL COMPOSITION WITH THE SAME.
MX9206305A (en) SUBSTITUTE BIPHENYLPYRIDONES, PROCEDURE FOR THEIR OBTAINMENT AND DRUG CONTAINING THEM.
ES2161291T3 (en) N- (INDOL-2-CARBONIL) AMIDAS AND DERIVATIVES AS INHIBITORS OF THE GLUCOGENO FOSFORILASA.
ES2182903T3 (en) USEFUL HETEROCICLICAL DERIVATIVES IN THE TREATMENT OF ALLERGIC OR Rheumatic Diseases, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PA8452201A1 (en) DERIVATIVES OF 9-DESOXO-9A-AZA-9A-HOMOERITROMICINA A C-4 "SUBSTITUTED.
ES2054860T3 (en) NEW DERIVATIVES OF 9-HALOGEN- (Z) -POSTTAGLANDINAS, PROCEDURE FOR ITS PREPARATION, AS WELL AS ITS USE AS MEDICINES.
ECSP941104A (en) DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ES2128307T3 (en) DERIVATIVES OF 1,4,7,10-TETRAAZA-CYCLODODECANES MONOSUSTITUTED IN N, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS THAT CONTAIN THEM.
BR9609503A (en) Compound, use of a compound, process of treatment of conditions where the inhibition of pg specific pgmp is of therapeutic benefit, in human or non-human animal body, pharmaceutical composition, and processes to prepare it and a compound
PT979244E (en) CYCLOSPORIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
MX9308016A (en) HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
MX9200894A (en) THERAPEUTIC COMPOSITIONS TO PROTECT AND RESURRECT MAMMALIAN CELLS AND METHODS TO PREPARE AND USE THEM.
AR012294A1 (en) DERIVATIVES OF SULFONAMIDE, A PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A MEDICINAL PRODUCT.
ES2129485T3 (en) DERIVATIVES OF GUANIDINOALKYL-1,1-BISPHOSPHONIC ACIDS, PROCEDURE FOR THEIR PREPARATION AND USE.
AR018501A1 (en) DERIVATIVES OF DOLASTATIN 15
ES2130152T3 (en) MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE.
ES2087623T3 (en) DERIVATIVES OF BENCIMIDAZOLE AS AN ANTIMICROBIAL AGENT AGAINST CAMPYLOBACTER PYLON.
ES2078507T3 (en) MEDICINES AND DERIVATIVES OF SULFONANILIDE.
CO4130200A1 (en) HELPFUL HIV PROTEASE INHIBITORS IN AIDS TREATMENT
BR9611276A (en) Compound pharmaceutical formulation process for treatment or prophylaxis of diseases or conditions of humans and use of a compound
ES2173195T3 (en) ANTHRACICLINE DERIVATIVES.

Legal Events

Date Code Title Description
PC2A Transfer granted

Owner name: BRITISH BIOTECH PHARMACEUTICALS LIMITED

FD1A Patent lapsed

Effective date: 20100528